Marie‐Pierre Sunyach

Author

Also Known As

M Sunyach, M. -P. Sunyach, M. P. Sunyach, M. Sunyach, M.-P. Sunyach, M.P Sunyach, M.P. Sunyach, Marie-Pierre Sunyach, Marie‐Pierre Sunyach, Sunyach, Marie-Pierre

125

Publications

Citations

H-Index

Concepts

All Affiliations

Centre Léon Bérard Inserm Institut Bergonié Institut Gustave Roussy Centre de Recherche en Cancérologie de Lyon

About

Marie‐Pierre Sunyach is an author at Centre Léon Bérard specializing in medicine, oncology, and radiation therapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	1.1K
2	Health Sciences	8	8	823
3	Radiation Medicine	4	4	639
4	Pathology	2	2	172
5	Biomedical Engineering	1	1	469

Marie‐Pierre Sunyach

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2–3, randomised, controlled trial Sylvie Bonvalot, Piotr Rutkowski, Juliette Thariat, The Lancet Oncology Radiation MedicineRadiation TherapyMedicineAdvanced Soft-tissue SarcomaRadiopharmaceutical Therapy	2019	469
Patterns of care and outcomes of patients with METAstatic soft tissue SARComa in a real-life setting: the METASARC observational study M. Savina, Axel Le Cesne, Jean‐Yves Blay, BMC Medicine	2017	206
Common Strategy for Adult and Pediatric Medulloblastoma: A Multicenter Series of 253 Adults Laëtitia Padovani, Marie‐Pierre Sunyach, David Pérol, International Journal of Radiation OncologyBiologyPhysics Neuro-oncologyPediatric Brain TumorsPediatric NeurosurgerySurgical PathologyCommon Strategy	2007	157
Results of a phase II pilot study of moderate dose radiotherapy for inoperable desmoid-type fibromatosis—an EORTC STBSG and ROG study (EORTC 62991–22998) Ronald B. Keus, Remi A. Nout, Jean‐Yves Blay, Annals of Oncology Radiation MedicineEortc 62991–22998Radiation TherapyRadiological SciencesMedicine	2013	134
Influence of Nucleoshuttling of the ATM Protein in the Healthy Tissues Response to Radiation Therapy: Toward a Molecular Classification of Human Radiosensitivity Adeline Granzotto, Mohamed Amine Benadjaoud, Guillaume Vogin, International Journal of Radiation OncologyBiologyPhysics Atm ProteinRadiation TherapyRadiobiologyMedicineRadionuclide Therapy	2015	119
Dose-painting multicenter phase III trial in newly diagnosed glioblastoma: the SPECTRO-GLIO trial comparing arm A standard radiochemotherapy to arm B radiochemotherapy with simultaneous integrated boost guided by MR spectroscopic imaging Anne Laprie, S. Ken, Thomas Filleron, BMC Cancer	2019	51
Localized Myxofibrosarcomas: Roles of Surgical Margins and Adjuvant Radiation Therapy Raoudha Boughzala-Bennadji, Eberhard Stoeckle, C. Le Péchoux, International Journal of Radiation OncologyBiologyPhysics Surgical OncologyTumoral PathologyRadiation TherapyMedicineHistopathology	2018	43
Assessment of Safety and Efficacy of Combined Trabectedin and Low-Dose Radiotherapy for Patients With Metastatic Soft-Tissue Sarcomas Javier Martín‐Broto, Nadia Hindi, Antonio López–Pousa, JAMA Oncology	2020	43
Brain metastases treated with hypofractionated stereotactic radiotherapy: 8 years experience after Cyberknife installation Laurence Mengue, Aurélie Bertaut, Louise Ngo Mbus, Radiation Oncology	2020	42
Final Safety and Health-Related Quality of LIfe Results of the Phase 2/3 Act.In.Sarc Study With Preoperative NBTXR3 Plus Radiation Therapy Versus Radiation Therapy in Locally Advanced Soft-Tissue Sarcoma Sylvie Bonvalot, Piotr Rutkowski, Juliette Thariat, International Journal of Radiation OncologyBiologyPhysics	2022	41

Page 1